2001
DOI: 10.1002/jnr.1069
|View full text |Cite
|
Sign up to set email alerts
|

Glial transporters for glutamate, glycine, and GABA III. Glycine transporters

Abstract: Glial cells possess transport systems for the three major amino acid neurotransmitters glutamate, ␥-aminobutyric acid (GABA) and glycine, involved in the arrest of neurotransmission mediated by these compounds. Two glycine transporters have been cloned: GLYT1, mainly expressed by glial cells and shown to colocalize with NMDA receptors, and GLYT2, exclusively expressed by neurons and colocalized with the inhibitory glycine receptors. The way in which the regulation of extracellular glycine concentration by glia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
21
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 49 publications
(23 citation statements)
references
References 57 publications
2
21
0
Order By: Relevance
“…We modified the metabolic pathways to include compartmentalization of NADH between the cytosol and mitochondria. To do so, we developed a very simple model of mitochondrial respiration and added NADH malate-aspartate shuttles between the cytosol and mitochondria, drawing inspiration from a model by [58]. Finally, the model is driven by external input modeled as a global excitatory presynaptic activity and coordinated increase of the cerebral blood flow.…”
Section: Resultsmentioning
confidence: 99%
“…We modified the metabolic pathways to include compartmentalization of NADH between the cytosol and mitochondria. To do so, we developed a very simple model of mitochondrial respiration and added NADH malate-aspartate shuttles between the cytosol and mitochondria, drawing inspiration from a model by [58]. Finally, the model is driven by external input modeled as a global excitatory presynaptic activity and coordinated increase of the cerebral blood flow.…”
Section: Resultsmentioning
confidence: 99%
“…GlyT1 has emerged as a promising pharmacological target to treat cognitive dysfunctions in schizophrenia or to enhance general cognition function (Atkinson et al, 2001; Gadea and Lopez-Colome, 2001; Chen et al, 2003). Following the discovery of neuronal GlyT1 (Cubelos et al, 2005), the cell-type specific roles of GlyT1 (neuronal vs. glial) in modifying cognitive functions have not been addressed.…”
Section: Discussionmentioning
confidence: 99%
“…1991). Ca 2+ ‐independent release has been ascribed to glial Gly transporters (reviewed in Gadea and López‐Colomé 2001a), which have a stoichiometry of 2/Na + /Cl – /Gly, versus neuronal ones, with 3Na + /Cl – /Gly stoichiometry (Roux and Supplisson 2000).…”
mentioning
confidence: 99%
“…Two different glycine transporters have been cloned: GLYT1, with three isoforms derived from alternative splicing and/or promoter usage termed GLYT1a, GLYT1b and GLYT1c, inhibited by sarcosine and expressed in glial cells throughout the CNS, and GLYT2, expressed predominantly in brain stem and spinal cord, where glycine is considered the major inhibitory neurotransmitter (reviewed in Gadea and López‐Colomé 2001a). GLYT1 thus, shows the expected properties for controlling extracellular Gly concentration, tonically modulating NMDA receptors, whereas GLYT2 could function in Gly accumulation at inhibitory glycinergic synapses.…”
mentioning
confidence: 99%